Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Trial of EMD 121974 in Patients With Advanced or Metastatic Cancer

NCT00004258 is registered in ClinicalTrials.gov with Indiana University as lead sponsor.

NCT NCT00004258
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00004258 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Trial of EMD 121974 in Patients With Advanced or Metastatic Cancer
Lead sponsor
Indiana University
Phase
Phase 1
Overall status
Completed
Start date
December 31, 1999
Completion date
September 30, 2001
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic myeloproliferative disorders, leukemia, lymphoma, multiple myeloma and plasma cell neoplasm, myelodysplastic syndromes, precancerous/nonmalignant condition, small intestine cancer, unspecified adult solid tumor, protocol specific